UCB’s Post

On this day I want to recognize the hard work, dedication, and amazing example of all people involved in clinical trials. 🙏🏽🙏🏽🙏🏽🙏🏽🙏🏽🙏🏽🙏🏽🙏🏽🙏🏽🙏🏽 I learned the hard way how important these trials are and how dependable we all are on these trials to be successful so that we have new and better treatments or just one more alternative, more hope. I am using the Clinical Trials Day to remind myself of the importance of: - Patient and Caregiver Involvement - Diversity and Inclusion - Proactive Planning and Management - Collaboration - Transparency - Teamwork - Beginner's Mindset We all need to focus on these things to make clinical trials more successful and to learn from the unsuccessful ones and evolve. I would like to thank my team also for fighting for our mission to Bring Research Closer to Patients. Through a million different challenges you never gave up on supporting Patients, Caregivers, and the Industry. You are true heroes! #HappyClinicalTrialsDay #clinicaltrials #patientsfirst #clinicaltrialrecruitment #clinicalresearch #standardofcare #trialhub #patientrecruitment #trialamendments #cro #cra #pharma #biotech #drugdevelopment #clinicalresearchassociates

The role of patient-owned medical data is transforming drug development, putting patients at the heart of biotech innovation. With increased control over their health information, patients are driving more accurate, representative clinical trials and fostering collaboration with advocacy groups. This shift is not just accelerating the development of new therapies but also ensuring they meet the real needs of patients. It’s a new era of patient-centric innovation in healthcare. #PatientCentricity #BiotechInnovation #Healthcare #DrugDevelopment #PatientAdvocacy https://lnkd.in/emAXGkFF

I wanted to share an exciting update on the progress we’re making at Every Cure. Through our dedicated medical team, we’re evaluating the most promising drug repurposing opportunities available. We’re carefully assessing the likelihood that each drug will work for specific diseases, the potential impact on patients, and the feasibility of studying these drugs in clinical trials. As always, safety remains our top priority. We’re incredibly fortunate to be partnering with Worldwide Clinical Trials, a group that specializes in advancing drugs for biotech companies. Together with experts like Dr. Michael Murphy M.D., Ph.D. they are helping us push forward these life-saving treatments. None of us can do this alone. That’s why we’re so grateful for partners like Worldwide Clinical Trials, and why we’re eager to connect with more organizations that can support our mission. If you have data, services, or expertise that can help unlock hidden cures, please reach out to us at [email protected] We’re all in this together! #DrugRepurposing #ClinicalTrials #EveryCure #HealthcareInnovation #MedicalResearch

What would be the key challenges of remote monitoring, as opposed to on-site monitoring in clinical trials? In an attempt to streamline and prioritise resources, there has been a shift towards a more targeted and risk-driven approach from the traditional on-site monitoring methods in the clinical trials space. Risk-based monitoring (RBM) heavily relies on early identification and mitigation of potential risks to implement a cost and time-effective method where unnecessary visits and oversight of low risk sites can be minimised for resource optimization. This can be a useful approach for incorporating flexibility in monitoring and make the process adaptable to evolving needs and various complexities of study protocols and trial designs. Overall, the purpose of RBM is to incorporate both remote and on-site monitoring, where needed. Have you encountered any key differences in remote vs on-site monitoring as an experienced CRA / monitor? Drop a comment :) #clinicaltrialsindustry #clinicalresearchassociate #drugdevelopment #medicaldevices #clinicalresearchorganisations #pharmacueticalindustry #onsitemonitoring #remotemonitoring #riskbasedmonitoring #dataverification #patientsafety #healthcare #lifesciences #medicalresearch #clinicaltrialprotocol #trialdesigns #sitemanagement #oncology #biotech #projectmanagement

I am happy to take part in the GSK STEP UP career challenge! Thank you Rachel Keane, for organising the GSK STEP UP live online career challenge. Giving a realm of insights into data science and data strategy, including emphasis on the use of data to develop pharmaceuticals, gain insight into drug activity, run statistical tests for future predictions, and create clinical trails. I learned from this experience to draw conclusions based on the given data about which patients benefited from the medicine and a better option for a more effective approach to standard care. Risk-to-benefit ratio and analysing trends in the usage of Miraculon-B among medical audiences.

The Top Players in Clinical Research: A Review of the Leading Companies https://lnkd.in/gPkEiPEN #ClinicalResearch #TopPlayers #LeadingCompanies #ResearchIndustry #HealthcareLeaders #InnovationInHealthcare #MedicalResearch #HealthcareTechnology

𝐓𝐡𝐞 𝐄𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐂𝐑𝐎 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐜𝐮𝐫𝐞 𝐚 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://lnkd.in/gYMi-V7q As we continue to navigate the complexities of the healthcare landscape, the role of Contract Research Organizations (CROs) is more pivotal than ever. Here’s a quick look at the current trends and future prospects within the 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐂𝐑𝐎 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐭 𝐭𝐡𝐞 𝐅𝐨𝐫𝐞𝐟𝐫𝐨𝐧𝐭: Advances in technology, including AI and big data analytics, are transforming how CROs operate, leading to faster patient recruitment and streamlined processes. 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐚𝐜𝐡: With increasing globalization, CROs are expanding their services across emerging markets, tapping into diverse patient populations and regulatory environments. 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬: Collaborations between CROs, biotech firms, and academic institutions are becoming more common, enhancing research capabilities and accelerating drug development. 𝐅𝐨𝐜𝐮𝐬 𝐨𝐧 𝐏𝐚𝐭𝐢𝐞𝐧𝐭-𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: CROs are prioritizing patient engagement, ensuring that trials are designed with patient needs in mind, ultimately improving retention and data quality. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: IQVIA Thermo Fisher Scientific Labcorp Parexel Charles River Laboratories ICON plc inVentiv Health Syneos Health Medidata Solutions WuXi AppTec As we look to the future, the Healthcare CRO market will continue to evolve, driven by innovation, collaboration, and a steadfast commitment to improving patient outcomes. 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/gzwzExqG What trends are you seeing in the CRO space? Share your thoughts below! #healthcare #cro #clinicaltrials #innovation #pharma #biotech #patientcentricity #marketresearch #markettrends #businessinsights #globalindustry

📌 The latest draft guidance from the FDA "Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies" is putting a key requirement on #DEI outcomes like never before. Now, Sponsors must present data on the safety and effectiveness of drugs and biologics across gender, age, and racial subgroups. Failing to ensure diverse representation could delay product approval or lead to rejection! 🚫 This means Sponsors need to tap into more research-naive and less experienced sites right in the neighborhoods where patients live. 🏘️ In a throwback to the Society for Clinical Research Sites (SCRS) IncluDE summit: Our Chief Strategy Officer Joseph K. along with Marland May, MS, Jane Williams MD MPH, MD, MPH, and Lisa Bjornestad, discussed strategies to support research-naive sites and the role of inclusive technology in improving clinical trial outcomes for everyone. Tune in to their discussion! #clinops #clinicalresearch #healthcarediversity #healthcaretrend #DiversityInResearch #HealthEquity #InclusiveResearch

"The last thing we want to do is bring a new investigator in, have them screw the study up because they haven't completed a lot of research, then saying "I told you so" - Joseph K. With every trial, there should be two levels of training: 𝟭. 𝗧𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗣𝗿𝗶𝗻𝗰𝗶𝗽𝗮𝗹 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗼𝗿𝘀 (𝗣𝗜𝘀) 𝘁𝗼 𝗯𝗲 𝗚𝗼𝗼𝗱 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗼𝗿𝘀 -> This is akin to teaching someone to be a good driver. However, just because someone knows how to be a good driver doesn't mean they can navigate from point A to point B without making wrong turns. 𝟮. 𝗣𝗿𝗼𝘃𝗶𝗱𝗶𝗻𝗴 𝗮 𝗦𝗲𝗰𝗼𝗻𝗱 𝗟𝗮𝘆𝗲𝗿 𝗼𝗳 𝗦𝘂𝗽𝗽𝗼𝗿𝘁 𝗮𝗻𝗱 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 -> Beyond initial training, we must offer continuous support and guidance to ensure investigators remain on the right path and avoid potential pitfalls. #clinicaltrials #DEI ProofPilot #clinicalguidance

"𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝑻𝒓𝒊𝒂𝒍𝒔" : !! In the "𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆" Sector !! [ 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐏𝐃𝐅 ] ➡𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐟𝐨𝐫 𝐏𝐃𝐅>> https://lnkd.in/dT-FM_af The growth of this market can be attributed to various factors, including increasing focus on rare diseases, rise in adoption of personalized medicine, increasing research and development expenditure, and improving recruitment in clinical trials resulting in the retention of participants. In clinical trials, remote patient monitoring makes it easier for patients to participate and improves recruitment through greater access to diverse patient populations. The use of wearable technology for clinical trials has offered new opportunities for better understanding patients and improving their experience in their journey of clinical trials. 𝗗𝗿𝗶𝘃𝗲𝗿𝘀           1.   Increasing Focus on Rare Diseases          2.   Rise in Adoption of Personalized Medicine          3.   Increasing Research and Development Expenditure          4.   Improvement in Recruitment Process in Clinical Trials Resulting in Retention of Participants #Keyplayers: Laboratory Corporation of America Holdings (U.S), Medpace, Inc. (U.S), Charles River Laboratories International, Inc. (U.S.), IQVIA Inc. (U.S.), Parexel International Corporation (U.S.), Syneos Health (U.S), ICON plc (Ireland), WuXi AppTec Co., Ltd. (China), Thermo Fisher Scientific Inc. (U.S). #clinicalresearch #clinicaltrials #medicine #research #healthcare #medicalresearch #clinicaltrial #science #clinical #health #clinicalstudies #pharma #medical #pharmacy #biotech #covid #biopharma #pharmaceuticals #clinicalstudy #pharmacovigilance #medicalaffairs #clinicalresearchassociate #pharmaindustry #doctor #pharmaceuticalindustry #phd #oncology #drugdevelopment #cra #biotechnology